R
3.69
0.06 (1.52%)
前收盘价格 | 3.63 |
收盘价格 | 3.69 |
成交量 | 43,479 |
平均成交量 (3个月) | 232,800 |
市值 | 170,029,584 |
价格/销量 (P/S) | 4.88 |
股市价格/股市净资产 (P/B) | 10.53 |
52周波幅 | |
利润日期 | 7 May 2025 |
营业毛利率 | -15.10% |
营业利益率 (TTM) | -12.92% |
稀释每股收益 (EPS TTM) | -0.120 |
季度收入增长率 (YOY) | 17.50% |
总债务/股东权益 (D/E MRQ) | 22.83% |
流动比率 (MRQ) | 2.44 |
杠杆自由现金流 (LFCF TTM) | 1.05 M |
资产报酬率 (ROA TTM) | -13.09% |
股东权益报酬率 (ROE TTM) | -29.87% |
市场趋势
短期 | 中期 | ||
行业 | Medical Instruments & Supplies (US) | 看跌 | 混合的 |
Medical Instruments & Supplies (全球的) | 看跌 | 看跌 | |
股票 | KORU Medical Systems, Inc. | 看跌 | 看跌 |
AIStockmoo 评分
0.2
分析师共识 | -3.5 |
内部交易活动 | 2.5 |
价格波动 | -2.0 |
技术平均移动指标 | 0.0 |
技术振荡指标 | 4.0 |
平均 | 0.20 |
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). |
|
部门 | Healthcare |
行业 | Medical Instruments & Supplies |
投资方式 | Small Core |
内部持股比例 | 7.60% |
机构持股比例 | 51.82% |
52周波幅 | ||
中 | 3.50 (-5.02%) | |
总计 | 1 保留 |
公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
---|---|---|---|---|
Piper Sandler | 08 May 2025 | 3.50 (-5.02%) | 保留 | 3.29 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合